Abstract:Adjuvant selection in vaccines is a key to induce potent immune responses. The current licensed adjuvant alum is found to be insufficient to induce cellular immune responses and a balanced Th1/Th2 ratio, which are desirable against cancers and microbial infections. Hence, it is encouraged to develop adjuvants which can simultaneously improve cell-mediated and humoral immune responses of the antigen and possess a favorable Th1/Th2 balance. Herein, quaternized cationic carbon dots derived from biquaternary ammonium salt (BQAS-CDs) were newly prepared, and their adjuvanticity and biocompatibility were preliminarily explored in vivo. The developed BQAS-CDs are enriched in quaternary ammonium groups on the surface, which enable them to bind to and aggregate with the negatively charged ovalbumin (OVA). The resulting BQAS-CDs + OVA nanocomplexes dramatically enhance the uptake of antigen by the antigen-presenting cells (APCs). Compared to the conventional adjuvant alum, the BQAS-CDs + OVA nanocomplexes significantly increase the anti-OVA IgG2a and IgG2b levels and keep the level of the OVA-specific IgG1 antibody, inducing both robust Th1- and Th2-type immune responses. Furthermore, they stimulate the proliferation of OVA-specific CD4+ and CD8+ T cells. No significant alterations were observed in the hematological and histological parameters of BQAS-CDs + OVA-immunized recipients. These findings suggest the potential benefits of BQAS-CDs as an alternative adjuvant in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsanm.0c02062?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsanm.0c02062</a>.EA results of BQAS and BQAS-CDs; QY calculations of BQAS-CDs; 1H NMR spectrum of BQAS; AFM results of BQAS-CDs; DLS results of BQAS-CDs; XRD patterns of BQAS-CDs; XPS spectra of BQAS-CDs and BQAS; PL spectra of BQAS-CDs at different pHs; effect of pH, ion strength, temperature, and UV irradiation time on BQAS-CDs; cytotoxicity test and cellular imaging results of BQAS-CDs; photograph of BQAS-CDs, OVA, and BQAS-CDs + OVA solutions; SEM images of OVA and BQAS-CDs + OVA; storage time effect on the size of BQAS-CDs + OVA; circular dichroism spectra of BQAS-CDs, OVA, and BQAS-CDs + OVA; UV–vis results of BQAS-CDs, OVA, and the upper solution of the BQAS-CDs + OVA complex after centrifugation; confocal fluorescence images of RAW264.7 cells cultured with BQAS-CDs + OVA-FITC or OVA-FITC; cellular uptake of BQAS-CDs + OVA at 4 °C; effect of BQAS-CDs on the body weight of vaccinated mice; and blood count analysis of mice with PBS- or OVA-based materials (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02062/suppl_file/an0c02062_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice

Preparation of OVA‐loaded γ‐PGA/CS nanocomposite delivery vector and its immune response

Chitosan Nanoparticles Act As an Adjuvant to Promote Both Th1 and Th2 Immune Responses Induced by Ovalbumin in Mice

Antigen-conjugated N-trimethylaminoethylmethacrylate Chitosan Nanoparticles Induce Strong Immune Responses after Nasal Administration

Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice

Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses

Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant

A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier

Adjuvant effect of an extract from Cochinchina momordica seeds on the immune responses to ovalbumin in mice

Probiotic-derived amphiphilic exopolysaccharide self-assembling adjuvant delivery platform for enhancing immune responses

pH-responsive Astragalus polysaccharide-loaded PLGA nanoparticles as an adjuvant system to improve immune responses

Preparation and Evaluation of Antigen/n-Trimethylaminoethylmethacrylate Chitosan Conjugates for Nasal Immunization

Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery

PEI-modified macrophage cell membrane-coated PLGA nanoparticles encapsulating Dendrobium polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses

Quaternized Cationic Carbon Dots as Antigen Delivery Systems for Improving Humoral and Cellular Immune Responses

β-glucan-modified nanoparticles with different particle sizes exhibit different lymphatic targeting efficiencies and adjuvant effects

Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination

Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8 + T Cell Responses

Ultrasmall Graphene Oxide Supported Gold Nanoparticles as Adjuvants Improve Humoral and Cellular Immunity in Mice

Self-Assembled Proteinaceous Nanoparticles for Co-Delivery of Antigens and Cytosine Phosphoguanine (CpG) Adjuvants: Implications for Nanovaccines

Cyclodextrin/chitosan nanoparticles for oral ovalbumin delivery: Preparation, characterization and intestinal mucosal immunity in mice